Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Accent Therapeutics

Accent Therapeutics is a RNA-modifying protein inhibitors founded in 2017 by Robert Copeland.

OverviewStructured DataIssuesContributorsActivity
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
0
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
contactus@accenttx.com
Founded Date
2017
0
Founder
‌
Robert Copeland
0
Industry
Medicine
Medicine
Healthcare
Healthcare
Internal medicine
Internal medicine
‌
Synthetic chemistry
Biotechnology
Biotechnology
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Cancer
Cancer
Oncology
Oncology
Investors
‌
The Mark Foundation For Cancer Research
DROIA Ventures
DROIA Ventures
The Column Group
The Column Group
Google Ventures
Google Ventures
Atlas Venture
Atlas Venture
AbbVie Ventures
AbbVie Ventures
EcoR1 Capital
EcoR1 Capital
Latest Funding Round Date
April 23, 2020
Latest Funding Round Amount (USD)
63,000,000
Latest Funding Type
Series B Round
Series B Round
LinkedIn URL
@company/accenttherapeutics
Location
Lexington, Massachusetts
Lexington, Massachusetts
United States
United States
Number of Employees (Ranges)
11 – 50
0
Phone Number
+13399707400
0
Pitchbook URL
pitchbook.com/profiles...228849-13
Total Funding Amount (USD)
103,000,000
Twitter URL
@accent_tx
Official Website
accenttx.com

Find more companies like Accent Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo